The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Ursofalk 250mg / 5ml Suspension



Dr. Falk Pharma GmbHPA0573/005/002

Main Information

Trade NameUrsofalk 250mg / 5ml Suspension
Active SubstancesUrsodeoxycholic acid
Dosage FormOral suspension
Licence HolderDr. Falk Pharma GmbH
Licence NumberPA0573/005/002

Group Information

ATC CodeA05AA Bile acid preparations
A05AA02 ursodeoxycholic acid

Status

License statusAuthorised
Licence Issued14/01/2011
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportPDF Version
« Back